Physician profile
Stanley Holstein
NPI 1720148869
$3,328.06
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,196 · 2020: $136 · 2021: $316 · 2022: $636 · 2023: $44.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $44.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $44.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $636.68 | 2019-2023 | Ultomiris |
| Teva Pharmaceuticals USA, INC. | $337.57 | 2019 | |
| Novartis Pharmaceuticals Corporation | $292.02 | 2019-2021 | |
| Emd Serono, INC. | $282.07 | 2019-2022 | |
| Acorda Therapeutics, INC | $230.77 | 2019-2022 | |
| Lilly USA, LLC | $179.36 | 2019 | |
| Sunovion Pharmaceuticals INC. | $154.69 | 2019-2022 | |
| Genentech USA, INC. | $154.33 | 2019 | |
| Biogen, INC. | $130.64 | 2019 | |
| Adamas Pharmaceuticals, INC. | $128.56 | 2019-2020 | |
| Akcea Therapeutics, INC. | $116.80 | 2019 | |
| Janssen Pharmaceuticals, INC | $92.66 | 2020-2022 | |
| Lundbeck LLC | $88.02 | 2019 | |
| Abbvie INC. | $85.51 | 2021-2022 | |
| Avion Pharmaceuticals | $68.25 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $56.60 | 2022 | |
| Amgen INC. | $52.15 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $47.12 | 2022 | |
| Ptc Therapeutics, INC. | $40.17 | 2019-2021 | |
| Pfizer INC. | $40.03 | 2019-2021 | |
| Amneal Pharmaceuticals LLC | $27.69 | 2022 | |
| Acadia Pharmaceuticals INC | $24.98 | 2022 | |
| Ns Pharma, INC. | $24.02 | 2022 | |
| Impel Pharmaceuticals INC. | $22.10 | 2022 | |
| Currax Pharmaceuticals LLC | $15.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanley Holstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.